2022

1. Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

   British Journal of Pharmacology, Vol. 179, Núm. 2, pp. 270-286

2. Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells

   Biomedicine and Pharmacotherapy, Vol. 155